BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16847368)

  • 1. Vogt-Koyanagi-Harada's disease presenting polymorphonuclear pleocytosis in the cerebrospinal fluid at the early active stage.
    Kato Y; Kurimura M; Yahata Y; Tajima K; Kato T
    Intern Med; 2006; 45(12):779-81. PubMed ID: 16847368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vogt-Koyanagi-Harada disease and polymorphonuclear leuokocyts pleocytosis in cerebrospinal fluid.
    Kira J
    Intern Med; 2006; 45(14):839-40. PubMed ID: 16908938
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease.
    Miyanaga M; Kawaguchi T; Shimizu K; Miyata K; Mochizuki M
    Int Ophthalmol; 2007; 27(2-3):183-8. PubMed ID: 17476572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis.
    Kamondi A; Szegedi A; Papp A; Seres A; Szirmai I
    Eur J Neurol; 2000 Nov; 7(6):719-22. PubMed ID: 11136362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harada's, Behcet's, Vogt-Koyanagi syndromes--are they clinical entities?
    Shimizu K
    Trans Am Acad Ophthalmol Otolaryngol; 1973; 77(3):OP281-90. PubMed ID: 4731490
    [No Abstract]   [Full Text] [Related]  

  • 6. Vogt-Koyanagi-Harada disease presenting meningoencephalitis. Report of a case with magnetic resonance imaging.
    Ikeda M; Tsukagoshi H
    Eur Neurol; 1992; 32(2):83-5. PubMed ID: 1373385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Vogt-Koyanagi- Harada's disease during pregnancy.
    Miyata N; Sugita M; Nakamura S; Isobe K; Matoba H; Tsuda K; Tanaka K; Ohno S
    Jpn J Ophthalmol; 2001; 45(2):177-80. PubMed ID: 11313051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Vogt-Koyanagi-Harada disease in a patient with Graves disease.
    Seo JH; Yu HG; Chung H
    Korean J Ophthalmol; 2009 Jun; 23(2):112-3. PubMed ID: 19568361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uveomeningoencephalitis (Harada's disease; Vogt-Koyanagi syndrome) (author's transl)].
    Uthoff D; Christiani K; Trettin H
    Nervenarzt; 1979 Jul; 50(7):464-6. PubMed ID: 530349
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of lumbar puncture in diagnosis of Vogt-Koyanagi-Harada disease.
    Tsai JH; Sukavatcharin S; Rao NA
    Int Ophthalmol; 2007; 27(2-3):189-94. PubMed ID: 17340216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC; Cho IH; Lee EK; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vogt-Koyanagi-Harada disease diagnostic criteria.
    Rao NA; Sukavatcharin S; Tsai JH
    Int Ophthalmol; 2007; 27(2-3):195-9. PubMed ID: 17384920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vogt-Koyanagi-Harada's disease: 3 cases].
    Mikou O; Chiheb S; Zouhair K; Jarmouni RI; Nejjam F; El Ouazzani T; Amraoui A; Lakhdar H
    Ann Dermatol Venereol; 2000 Mar; 127(3):282-4. PubMed ID: 10804302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of anterior chamber depth measurement for efficacy assessment of steroid pulse therapy in patients with Vogt-Koyanagi-Harada disease.
    Otsuki T; Shimizu K; Igarashi A; Kamiya K
    Jpn J Ophthalmol; 2010 Sep; 54(5):396-400. PubMed ID: 21052900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vogt-Koyanagi-Harada disease in monozygotic twins.
    Itho S; Kurimoto S; Kouno T
    Int Ophthalmol; 1992 Jan; 16(1):49-54. PubMed ID: 1537650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
    Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
    Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt Koyanagi Harada (VKH) syndrome.
    Tubridy N; Redmond J; O'Connor M
    Ir Med J; 1996; 89(2):53. PubMed ID: 8682628
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between severity of inflammation in CNS and development of sunset glow fundus in Vogt-Koyanagi-Harada disease.
    Keino H; Goto H; Mori H; Iwasaki T; Usui M
    Am J Ophthalmol; 2006 Jun; 141(6):1140-1142. PubMed ID: 16765691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA; Sanchis ME; Fernandez-Munoz M
    J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.